CME Group (CME)
CME Group on one page: short interest, daily short volume, fails to deliver, planned sales, large holders, 13F holders, financials, earnings dates and insider trades. Listed on Nasdaq, classified by the SEC as security & commodity brokers, dealers, exchanges & services.
5.0M
Short interest
settlement 2026-10-15
2.6
Days to cover
-0.6 days vs prior
37.8%
Short share of volume
2026-11-02
1,121
Fails to deliver
settlement 2026-10-13
Wed 3 Feb
Next earnings
estimated date
-$8.9M
Insider flow, 90 days
1 buys, 6 sells
As of 2026-11-02.
Short interest
FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSONAs of 15 October 2026, short interest in CME is 4,987,983 shares, down 813,581 shares over the last month. Over the last 48 readings it ranged from 3,812,422 shares (15 November 2024) to 6,213,476 shares (31 July 2026). At the reported average volume of 1.9M shares a day that is 2.6 days to cover.
Embed this chart.The embed keeps its attribution line.
<iframe src="https://xoomar.com/embed/stocks/cme" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>
| Settlement | Shares short | Change | Avg daily volume | Days to cover |
|---|---|---|---|---|
| 2026-10-15 | 4,987,983 | -9.7% | 1,930,869 | 2.58 |
| 2026-09-30 | 5,526,063 | -4.8% | 1,744,545 | 3.17 |
| 2026-09-15 | 5,801,564 | +3.1% | 1,736,223 | 3.34 |
| 2026-08-31 | 5,629,176 | +8.3% | 1,987,880 | 2.83 |
| 2026-08-14 | 5,199,595 | -16.3% | 1,677,148 | 3.10 |
| 2026-07-31 | 6,213,476 | +6.4% | 2,755,420 | 2.26 |
| 2026-07-15 | 5,837,310 | -2.9% | 3,110,735 | 1.88 |
| 2026-06-30 | 6,011,422 | +15.3% | 4,845,209 | 1.24 |
| 2026-06-15 | 5,212,475 | +14.1% | 4,171,632 | 1.25 |
| 2026-05-29 | 4,566,985 | -4.5% | 2,692,253 | 1.70 |
| 2026-05-15 | 4,782,505 | +16.5% | 2,290,264 | 2.09 |
| 2026-04-30 | 4,104,206 | -14.6% | 2,445,719 | 1.68 |
| 2026-04-15 | 4,804,467 | +2.3% | 2,234,378 | 2.15 |
| 2026-03-31 | 4,696,093 | -15.6% | 2,035,239 | 2.31 |
| 2026-03-13 | 5,566,514 | +12.5% | 2,430,984 | 2.29 |
| 2026-02-27 | 4,946,234 | -7.9% | 2,253,891 | 2.19 |
| 2026-02-13 | 5,372,152 | +3.2% | 2,598,006 | 2.07 |
| 2026-01-30 | 5,207,550 | +23.6% | 1,870,040 | 2.78 |
| 2026-01-15 | 4,213,842 | -15.7% | 2,106,738 | 2.00 |
| 2025-12-31 | 4,995,418 | -18.9% | 1,447,462 | 3.45 |
| 2025-12-15 | 6,158,003 | +24.4% | 1,907,748 | 3.23 |
| 2025-11-28 | 4,948,926 | -8.5% | 2,105,335 | 2.35 |
| 2025-11-14 | 5,410,273 | +31.7% | 1,907,310 | 2.84 |
| 2025-10-31 | 4,107,908 | -8.6% | 1,746,714 | 2.35 |
| 2025-10-15 | 4,493,938 | +8.9% | 1,920,990 | 2.34 |
| 2025-09-30 | 4,126,036 | -10.9% | 1,842,257 | 2.24 |
| 2025-09-15 | 4,629,679 | +2.5% | 1,954,656 | 2.37 |
| 2025-08-29 | 4,516,523 | -11.1% | 1,816,485 | 2.49 |
| 2025-08-15 | 5,080,621 | -6.3% | 1,971,095 | 2.58 |
| 2025-07-31 | 5,421,541 | +14.7% | 2,177,198 | 2.49 |
| 2025-07-15 | 4,728,942 | -9.7% | 2,022,705 | 2.34 |
| 2025-06-30 | 5,235,546 | -7.7% | 3,181,372 | 1.65 |
| 2025-06-13 | 5,674,828 | +13.6% | 2,226,487 | 2.55 |
| 2025-05-30 | 4,997,774 | +5.5% | 2,096,556 | 2.38 |
| 2025-05-15 | 4,737,717 | -5.8% | 2,197,017 | 2.16 |
| 2025-04-30 | 5,030,883 | +1.4% | 2,269,302 | 2.22 |
| 2025-04-15 | 4,959,787 | -12.8% | 3,690,275 | 1.34 |
| 2025-03-31 | 5,688,871 | +3.2% | 2,695,714 | 2.11 |
| 2025-03-14 | 5,514,711 | +10.0% | 2,983,559 | 1.85 |
| 2025-02-28 | 5,013,683 | -0.2% | 1,586,578 | 3.16 |
| 2025-02-14 | 5,023,940 | +12.0% | 1,720,104 | 2.92 |
| 2025-01-31 | 4,484,571 | -7.0% | 1,786,959 | 2.51 |
| 2025-01-15 | 4,820,775 | +11.6% | 2,051,203 | 2.35 |
| 2024-12-31 | 4,320,607 | -8.6% | 1,731,111 | 2.50 |
| 2024-12-13 | 4,726,046 | -3.5% | 2,883,932 | 1.64 |
| 2024-11-29 | 4,898,451 | +28.5% | 2,151,162 | 2.28 |
| 2024-11-15 | 3,812,422 | -0.4% | 1,776,731 | 2.15 |
| 2024-10-31 | 3,828,528 | +5.4% | 1,413,379 | 2.71 |
Daily short volume
FINRA Reg SHO, the last 30 sessions. JSONAs of 2 November 2026, the short share of CME volume is 37.8%, down 1.6 points over the last five sessions. Over the last 30 readings it ranged from 22.5% (1 October 2026) to 52.8% (30 October 2026). The latest reading is in line with the 30-session average of 39.8%, on 751K shares reported.
| Date | Short volume | Total volume | Short share | Exempt |
|---|---|---|---|---|
| 2026-11-02 | 284K | 751K | 37.8% | 398 |
| 2026-10-30 | 353K | 669K | 52.8% | 1,210 |
| 2026-10-29 | 253K | 711K | 35.5% | 7 |
| 2026-10-28 | 185K | 518K | 35.8% | 313 |
| 2026-10-27 | 381K | 783K | 48.6% | 309 |
| 2026-10-26 | 325K | 823K | 39.4% | 1,048 |
| 2026-10-23 | 288K | 617K | 46.8% | 834 |
| 2026-10-22 | 304K | 940K | 32.4% | 116 |
| 2026-10-21 | 223K | 737K | 30.2% | 0 |
| 2026-10-20 | 473K | 1.1M | 44.8% | 20 |
| 2026-10-19 | 412K | 883K | 46.7% | 2,265 |
| 2026-10-16 | 303K | 680K | 44.6% | 90 |
| 2026-10-15 | 319K | 783K | 40.7% | 11 |
| 2026-10-14 | 401K | 774K | 51.8% | 0 |
| 2026-10-13 | 282K | 549K | 51.3% | 150 |
| 2026-10-12 | 217K | 507K | 42.7% | 0 |
| 2026-10-09 | 457K | 1.2M | 36.7% | 10 |
| 2026-10-08 | 493K | 2.0M | 24.8% | 214 |
| 2026-10-07 | 194K | 514K | 37.9% | 123 |
| 2026-10-06 | 276K | 608K | 45.5% | 1 |
| 2026-10-05 | 203K | 551K | 36.9% | 626 |
| 2026-10-02 | 210K | 580K | 36.2% | 0 |
| 2026-10-01 | 255K | 1.1M | 22.5% | 0 |
| 2026-09-30 | 211K | 671K | 31.4% | 572 |
| 2026-09-29 | 258K | 610K | 42.3% | 1,113 |
| 2026-09-28 | 182K | 437K | 41.6% | 624 |
| 2026-09-25 | 298K | 926K | 32.2% | 125 |
| 2026-09-24 | 204K | 471K | 43.4% | 72 |
| 2026-09-23 | 179K | 468K | 38.2% | 8 |
| 2026-09-22 | 262K | 626K | 41.8% | 251 |
Fails to deliver
SEC, the last 30 settlement dates with a fail. JSONAs of 13 October 2026, the fails-to-deliver balance in CME is 1,121 shares, up 946 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (14 May 2026) to 57,703 shares (28 September 2026). The latest reading sits at the bottom of that range.
| Settlement | Shares failed | Price | Value |
|---|---|---|---|
| 2026-10-13 | 1,121 | $277.24 | $311K |
| 2026-10-09 | 175 | $276.44 | $48K |
| 2026-10-08 | 17 | $270.27 | $5K |
| 2026-10-06 | 122 | $270.03 | $33K |
| 2026-10-05 | 110 | $263.14 | $29K |
| 2026-10-02 | 120 | $265.10 | $32K |
| 2026-09-28 | 57,703 | $264.48 | $15.3M |
| 2026-09-01 | 1 | $285.50 | $286 |
| 2026-08-31 | 1,703 | $285.80 | $487K |
| 2026-08-28 | 146 | $280.94 | $41K |
| 2026-08-24 | 250 | $274.98 | $69K |
| 2026-08-14 | 64 | $267.21 | $17K |
| 2026-08-05 | 50,678 | $262.63 | $13.3M |
| 2026-08-04 | 11,653 | $266.17 | $3.1M |
| 2026-08-03 | 16,987 | $267.79 | $4.5M |
| 2026-07-27 | 395 | $255.31 | $101K |
| 2026-07-21 | 38,895 | $245.11 | $9.5M |
| 2026-07-07 | 14 | $234.76 | $3K |
| 2026-07-01 | 54 | $220.83 | $12K |
| 2026-06-26 | 31 | $225.00 | $7K |
| 2026-06-22 | 6 | $246.38 | $1K |
| 2026-06-16 | 1 | $266.08 | $266 |
| 2026-06-15 | 99 | $269.53 | $27K |
| 2026-06-11 | 23 | $263.80 | $6K |
| 2026-06-08 | 19 | $257.40 | $5K |
| 2026-06-03 | 22 | $250.53 | $6K |
| 2026-06-02 | 472 | $257.76 | $122K |
| 2026-05-20 | 4 | $302.37 | $1K |
| 2026-05-14 | 1 | $297.13 | $297 |
| 2026-05-07 | 2 | $288.34 | $577 |
Insider trades
SEC Form 4, newest first. JSONOver the last 90 days CME insiders reported 1 open-market buy ($79K) against 6 sells ($8.9M), so the dollar flow leans toward selling. Latest filing: Winkler Julie (Sr MD Chief Commercial Officer) on 2026-11-02.
| Date | Insider | Title | Type | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|---|
| 2026-11-02 | Winkler Julie | Sr MD Chief Commercial Officer | Sell | 10K | $305.15 | $3.1M | 21K |
| 2026-10-27 | Cutinho Sunil | Chief Information Officer | Sell | 5K | $298.70 | $1.5M | 20K |
| 2026-10-22 | GEPSMAN MARTIN J | Director | Sell | 400 | $302.50 | $121K | 25K |
| 2026-09-25 | SHEPARD WILLIAM R | Director | Buy | 293 | $268.76 | $79K | 263K |
| 2026-09-16 | Dennis Michael G. | Global Head of Fixed Income | Tax withholding | 274 | $272.46 | $75K | 11K |
| 2026-09-16 | Cutinho Sunil | Chief Information Officer | Tax withholding | 359 | $272.46 | $98K | 25K |
| 2026-09-16 | Fitzpatrick Lynne | President and CFO | Tax withholding | 359 | $272.46 | $98K | 27K |
| 2026-09-16 | Marchese John Clifford | Sr MD, General Counsel | Tax withholding | 44 | $272.46 | $12K | 4K |
| 2026-09-16 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Tax withholding | 364 | $272.46 | $99K | 13K |
| 2026-09-16 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Tax withholding | 359 | $272.46 | $98K | 10K |
| 2026-09-16 | Sprague Suzanne | COO & Global Head of Clearing | Tax withholding | 308 | $272.46 | $84K | 16K |
| 2026-09-16 | Tobin Jack J | MD Chief Accounting Officer | Tax withholding | 51 | $272.46 | $14K | 26K |
| 2026-09-16 | Vroman Ken | Chief Transformation Officer | Tax withholding | 308 | $272.46 | $84K | 20K |
| 2026-09-16 | Winkler Julie | Sr MD Chief Commercial Officer | Tax withholding | 359 | $272.46 | $98K | 32K |
| 2026-09-15 | Dennis Michael G. | Global Head of Fixed Income | Tax withholding | 274 | $275.09 | $75K | 11K |
| 2026-09-15 | Dennis Michael G. | Global Head of Fixed Income | Grant | 3K | $275.09 | $713K | 11K |
| 2026-09-15 | Cutinho Sunil | Chief Information Officer | Tax withholding | 320 | $275.09 | $88K | 25K |
| 2026-09-15 | Cutinho Sunil | Chief Information Officer | Tax withholding | 361 | $275.09 | $99K | 26K |
| 2026-09-15 | Cutinho Sunil | Chief Information Officer | Tax withholding | 373 | $275.09 | $103K | 26K |
| 2026-09-15 | Cutinho Sunil | Chief Information Officer | Grant | 3K | $275.09 | $788K | 26K |
| 2026-09-15 | DUFFY TERRENCE A | Chairman and CEO | Grant | 22K | $275.09 | $6.0M | 62K |
| 2026-09-15 | Fitzpatrick Lynne | President and CFO | Tax withholding | 457 | $275.09 | $126K | 27K |
| 2026-09-15 | Fitzpatrick Lynne | President and CFO | Tax withholding | 275 | $275.09 | $76K | 27K |
| 2026-09-15 | Fitzpatrick Lynne | President and CFO | Tax withholding | 249 | $275.09 | $68K | 28K |
| 2026-09-15 | Fitzpatrick Lynne | President and CFO | Grant | 4K | $275.09 | $1.1M | 28K |
| 2026-09-15 | Marchese John Clifford | Sr MD, General Counsel | Tax withholding | 50 | $275.09 | $14K | 4K |
| 2026-09-15 | Marchese John Clifford | Sr MD, General Counsel | Tax withholding | 57 | $275.09 | $16K | 4K |
| 2026-09-15 | Marchese John Clifford | Sr MD, General Counsel | Tax withholding | 47 | $275.09 | $13K | 4K |
| 2026-09-15 | Marchese John Clifford | Sr MD, General Counsel | Tax withholding | 43 | $275.09 | $12K | 4K |
| 2026-09-15 | Marchese John Clifford | Sr MD, General Counsel | Grant | 784 | $275.09 | $216K | 4K |
| 2026-09-15 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Tax withholding | 338 | $275.09 | $93K | 14K |
| 2026-09-15 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Tax withholding | 330 | $275.09 | $91K | 14K |
| 2026-09-15 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Tax withholding | 302 | $275.09 | $83K | 14K |
| 2026-09-15 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Grant | 3K | $275.09 | $713K | 15K |
| 2026-09-15 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Tax withholding | 320 | $275.09 | $88K | 10K |
| 2026-09-15 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Tax withholding | 361 | $275.09 | $99K | 11K |
| 2026-09-15 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Tax withholding | 373 | $275.09 | $103K | 11K |
| 2026-09-15 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Grant | 3K | $275.09 | $788K | 12K |
| 2026-09-15 | Sprague Suzanne | COO & Global Head of Clearing | Tax withholding | 320 | $275.09 | $88K | 16K |
| 2026-09-15 | Sprague Suzanne | COO & Global Head of Clearing | Tax withholding | 275 | $275.09 | $76K | 16K |
| 2026-09-15 | Sprague Suzanne | COO & Global Head of Clearing | Tax withholding | 249 | $275.09 | $68K | 16K |
| 2026-09-15 | Sprague Suzanne | COO & Global Head of Clearing | Grant | 3K | $275.09 | $788K | 17K |
| 2026-09-15 | Tobin Jack J | MD Chief Accounting Officer | Tax withholding | 205 | $275.09 | $56K | 26K |
| 2026-09-15 | Tobin Jack J | MD Chief Accounting Officer | Tax withholding | 47 | $275.09 | $13K | 26K |
| 2026-09-15 | Tobin Jack J | MD Chief Accounting Officer | Tax withholding | 44 | $275.09 | $12K | 26K |
| 2026-09-15 | Tobin Jack J | MD Chief Accounting Officer | Grant | 700 | $275.09 | $193K | 26K |
| 2026-09-15 | Vroman Ken | Chief Transformation Officer | Tax withholding | 274 | $275.09 | $75K | 21K |
| 2026-09-15 | Vroman Ken | Chief Transformation Officer | Tax withholding | 309 | $275.09 | $85K | 21K |
| 2026-09-15 | Vroman Ken | Chief Transformation Officer | Tax withholding | 320 | $275.09 | $88K | 21K |
| 2026-09-15 | Vroman Ken | Chief Transformation Officer | Grant | 3K | $275.09 | $713K | 21K |
| 2026-09-15 | Winkler Julie | Sr MD Chief Commercial Officer | Tax withholding | 320 | $275.09 | $88K | 32K |
| 2026-09-15 | Winkler Julie | Sr MD Chief Commercial Officer | Tax withholding | 361 | $275.09 | $99K | 32K |
| 2026-09-15 | Winkler Julie | Sr MD Chief Commercial Officer | Tax withholding | 373 | $275.09 | $103K | 33K |
| 2026-09-15 | Winkler Julie | Sr MD Chief Commercial Officer | Grant | 3K | $275.09 | $788K | 33K |
| 2026-09-14 | Cook Elizabeth A | Director | Sell | 500 | $280.11 | $140K | 18K |
| 2026-09-10 | DUFFY TERRENCE A | Chairman and CEO | Sell | 628 | $275.03 | $173K | 41K |
| 2026-09-10 | DUFFY TERRENCE A | Chairman and CEO | Sell | 14K | $274.41 | $3.9M | 41K |
| 2026-08-18 | SHEPARD WILLIAM R | Director | Other transaction | 3K | $0.00 | $0 | 263K |
| 2026-08-18 | SHEPARD WILLIAM R | Director | Other transaction | 3K | $0.00 | $0 | 1K |
| 2026-06-25 | Cook Elizabeth A | Director | Grant | 645 | $225.00 | $145K | 18K |
| 2026-06-25 | Durkin Bryan T | Director | Grant | 645 | $225.00 | $145K | 44K |
| 2026-06-25 | Hobert William W | Director | Grant | 422 | $225.00 | $95K | 108K |
| 2026-06-25 | Hobert William W | Director | Grant | 645 | $225.00 | $145K | 108K |
| 2026-06-25 | Kaye Daniel G | Director | Grant | 645 | $225.00 | $145K | 5K |
| 2026-06-25 | Lockett Phyllis M | Director | Grant | 645 | $225.00 | $145K | 4K |
| 2026-06-25 | Maloney Patrick W | Director | Grant | 645 | $225.00 | $145K | 5K |
| 2026-06-25 | Mulchrone Patrick J | Director | Grant | 645 | $225.00 | $145K | 29K |
| 2026-06-25 | Suskind Dennis | Director | Grant | 645 | $225.00 | $145K | 3K |
| 2026-06-25 | Seifu Rahael | Director | Grant | 645 | $225.00 | $145K | 5K |
| 2026-06-25 | SHEPARD WILLIAM R | Director | Buy | 14 | $230.57 | $3K | 4K |
| 2026-06-25 | SHEPARD WILLIAM R | Director | Buy | 325 | $230.57 | $75K | 260K |
| 2026-06-25 | Tierney Robert J JR | Director | Grant | 645 | $225.00 | $145K | 14K |
| 2026-06-25 | Carey Charles P | Director | Grant | 422 | $225.00 | $95K | 7K |
| 2026-06-25 | Carey Charles P | Director | Grant | 645 | $225.00 | $145K | 6K |
| 2026-06-25 | Lucas Deborah J | Director | Grant | 645 | $225.00 | $145K | 5K |
| 2026-06-25 | SIEGEL HOWARD J | Director | Grant | 422 | $225.00 | $95K | 49K |
| 2026-06-25 | SIEGEL HOWARD J | Director | Grant | 645 | $225.00 | $145K | 48K |
| 2026-06-25 | SHEPARD WILLIAM R | Director | Buy | 325 | $230.57 | $75K | 260K |
| 2026-06-25 | SHEPARD WILLIAM R | Director | Buy | 14 | $230.57 | $3K | 4K |
| 2026-06-25 | SHEPARD WILLIAM R | Director | Grant | 422 | $225.00 | $95K | 4K |
| 2026-06-25 | SHEPARD WILLIAM R | Director | Grant | 645 | $225.00 | $145K | 3K |
| 2026-06-25 | GEPSMAN MARTIN J | Director | Grant | 645 | $225.00 | $145K | 26K |
| 2026-06-25 | Ford Harold Eugene Jr. | Director | Grant | 422 | $225.00 | $95K | 2K |
| 2026-06-25 | Ford Harold Eugene Jr. | Director | Grant | 645 | $225.00 | $145K | 2K |
| 2026-06-25 | Bitsberger Timothy S. | Director | Grant | 645 | $225.00 | $145K | 12K |
| 2026-06-25 | Benesh Kathryn | Director | Grant | 645 | $225.00 | $145K | 3K |
| 2026-05-25 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Other transaction | 5K | $0.00 | $0 | 16K |
| 2026-05-25 | Sammann Derek | Sr MD Gl Hd Commodities Mkts | Other transaction | 5K | $0.00 | $0 | 9K |
| 2026-05-18 | Piell Hilda Harris | Sr MD & Chief HR Officer | Sell | 6K | $304.63 | $1.8M | 28K |
| 2026-05-15 | DUFFY TERRENCE A | Chairman and CEO | Sell | 9K | $299.58 | $2.7M | 56K |
| 2026-05-15 | DUFFY TERRENCE A | Chairman and CEO | Sell | 26K | $298.14 | $7.8M | 65K |
| 2026-05-01 | Hobert William W | Director | Other transaction | 20K | price not stated in the filing | not stated | 107K |
| 2026-03-26 | SHEPARD WILLIAM R | Director | Buy | 62 | $297.38 | $18K | 3K |
| 2026-03-26 | SHEPARD WILLIAM R | Director | Buy | 1K | $297.38 | $419K | 260K |
| 2026-03-17 | Marcus Jonathan L | Sr MD General Counsel | Sell | 3K | $313.37 | $1.0M | 7K |
| 2026-03-17 | Marcus Jonathan L | Sr MD General Counsel | Sell | 3K | $333.37 | $1.1M | 7K |
| 2026-03-15 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Tax withholding | 94 | $311.40 | $29K | 12K |
| 2026-03-15 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Tax withholding | 3K | $311.40 | $875K | 12K |
| 2026-03-15 | McCourt Timothy Francis | Sr MD Global Head Equity & FX | Grant | 6K | $311.40 | $1.7M | 15K |
| 2026-03-15 | Marcus Jonathan L | Sr MD General Counsel | Tax withholding | 261 | $311.40 | $81K | 10K |
Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.
Planned sales (Form 144)
Newest first. JSON18 Form 144 notices on file for CME worth $21.0M at the prices reported; 6 in the last 90 days worth $5.5M. Latest: JULIE WINKLER filed on 2026-11-02 to sell 10,079 shares ($3.1M) from 2026-11-02.
| Filed | Seller | Shares | Market value | Of outstanding | Sale from | Broker |
|---|---|---|---|---|---|---|
| 2026-11-02 | JULIE WINKLEROfficer | 10K | $3.1M | 0.003% | 2026-11-02 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-11-02 | SIEGEL HOWARD JDirector | 2K | $606K | 0.001% | 2026-11-02 | Fidelity Brokerage Services LLC |
| 2026-10-27 | SUNIL CUTINHOOfficer | 5K | $1.5M | 0.001% | 2026-10-27 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-10-22 | MARTIN J GEPSMANDirector | 400 | $121K | 0.000% | 2026-10-22 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-16 | JONATHAN MARCUSOfficer | 388 | $106K | 0.000% | 2026-09-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-09-14 | ELIZABETH ANNE COOK TRUSTDirector | 500 | $140K | 0.000% | 2026-09-14 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-05-18 | HILDA PIELL 1998 TROfficer | 6K | $1.8M | 0.002% | 2026-05-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-17 | JONATHAN MARCUSOfficer | 3K | $1.0M | 0.001% | 2026-03-17 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-12 | KENDAL VROMANOfficer | 5K | $1.6M | 0.001% | 2026-03-12 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-03-06 | ELIZABETH ANNE COOK TRUST U/A DTD 01/08/1999Director | 1K | $320K | 0.000% | 2026-03-06 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-23 | BRYAN T DURKIN REVOCABLE TRUSTDirector | 4K | $1.3M | 0.001% | 2026-02-23 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2026-02-18 | GEPSMAN MARTIN JDirector | 300 | $91K | 0.000% | 2026-02-18 | Commonwealth Financial Network |
| 2026-02-06 | Dennis SuskindDirector | 748 | $222K | 0.000% | 2026-02-06 | J.P. Morgan Securities LLC |
| 2025-12-11 | Terrence Duffyofficer | 25K | $6.7M | n/a | 2025-12-11 | Merrill |
| 2025-11-20 | Sammann DerekDirector | 7K | $2.0M | 0.002% | 2025-11-20 | Charles Schwab corporation |
| 2025-11-03 | HAROLD E FORD JR.Director | 1K | $264K | 0.000% | 2025-11-03 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-18 | JONATHAN MARCUSOfficer | 392 | $103K | 0.000% | 2025-09-18 | Morgan Stanley Smith Barney LLC Executive Financial Services |
| 2025-09-16 | JONATHAN MARCUSOfficer | 376 | $97K | 0.000% | 2025-09-16 | Morgan Stanley Smith Barney LLC Executive Financial Services |
Large holders (13D and 13G)
One row per reporting person with its latest filing, newest first. JSON1 holder reports 5% or more of CME in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (27,044,709 shares), filed 2026-04-29 for an event on 2026-03-31.
| Filed | Form | Holder | Shares | Of class | Event |
|---|---|---|---|---|---|
| 2026-04-29 | 13G | Vanguard Capital Managementinvestment adviser | 27.0M | 7.5% | 2026-03-31 |
| 2026-03-26 | 13G/Ano. 10 | The Vanguard Groupinvestment adviser | 0 | 0.0% | 2026-03-13 |
13F holders
Tracked managers holding CME at their latest 13F. JSON11 of the 30 tracked managers held CME at their latest 13F, $2.36B in total at quarter-end prices. Two Sigma Investments is the largest at $534.4M (0.4% of its portfolio) as of 2026-06-30. Over the prior quarter 10 added shares and 0 cut.
| Fund | Quarter | Shares | Value | Of portfolio | Change in shares |
|---|---|---|---|---|---|
| Two Sigma Investments | 2026-06-30 | 2.4M | $534.4M | 0.39% | +1.3M |
| AQR Capital Management | 2026-06-30 | 2.0M | $447.7M | 0.16% | +45K |
| Citadel Advisors | 2026-06-30 | 1.5M | $332.4M | 0.04% | +1.1M |
| D. E. Shaw & Co. | 2026-06-30 | 1.3M | $292.2M | 0.14% | +1.2M |
| Millennium Management | 2026-06-30 | 1.2M | $264.1M | 0.10% | +1.0M |
| Point72 Asset Management | 2026-06-30 | 744K | $164.2M | 0.18% | +654K |
| Renaissance Technologies | 2026-06-30 | 680K | $150.2M | 0.21% | +645K |
| Baupost Group | 2026-06-30 | 619K | $136.7M | 2.52% | new |
| Viking Global Investors | 2026-06-30 | 153K | $33.8M | 0.10% | new |
| Soros Fund Management | 2026-06-30 | 30K | $6.6M | 0.08% | 0 |
| Fisher Asset Management | 2026-06-30 | 1K | $314K | 0.00% | +240 |
Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.
Financials
SEC XBRL, as filed. JSONIn Q3 FY 2026 (quarter ended 2026-09-30) CME Group reported revenue of $1.74B, up 13.0% from the same quarter a year earlier, and net income of $1.04B (2.89 diluted EPS). In FY 2025 it generated $4.28B of operating cash flow and spent $3.93B on dividends.
- Cash
- $2.20B
- Equity
- $26.56B
- Total assets
- $192.09B
- Shares outstanding
- 66,643,583
Quarterly, last 8 quarters
| Quarter | Period end | Revenue | Net income | Margin | Diluted EPS |
|---|---|---|---|---|---|
| Q3 FY 2026 | 2026-09-30 | $1.74B | $1.04B | 59.7% | 2.89 |
| Q2 FY 2026 | 2026-06-30 | $1.71B | $1.04B | 61.1% | 2.88 |
| Q1 FY 2026 | 2026-03-31 | $1.88B | n/a | n/a | 3.18 |
| Q4 FY 2025derived | 2025-12-31 | $1.65B | n/a | n/a | n/a |
| Q3 FY 2025 | 2025-09-30 | $1.54B | $908.0M | 59.1% | 2.49 |
| Q2 FY 2025 | 2025-06-30 | $1.69B | $1.03B | 60.6% | 2.81 |
| Q1 FY 2025 | 2025-03-31 | $1.64B | n/a | n/a | 2.62 |
| Q4 FY 2024derived | 2024-12-31 | $1.53B | n/a | n/a | n/a |
Fiscal years, with buybacks and dividends
| Fiscal year | Ends | Revenue | Net income | Operating cash flow | Capex | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| FY 2025 | 2025-12-31 | $6.52B | $4.07B | $4.28B | $83.5M | n/a | $3.93B |
| FY 2024 | 2024-12-31 | $6.13B | $3.53B | $3.69B | $94.0M | n/a | $3.58B |
| FY 2023 | 2023-12-31 | $5.58B | $3.23B | $3.45B | $76.4M | n/a | $3.24B |
| FY 2022 | 2022-12-31 | $5.02B | $2.69B | $3.06B | $89.7M | n/a | $2.63B |
| FY 2021 | 2021-12-31 | $4.69B | $2.64B | $2.40B | $127.2M | n/a | $2.19B |
Quarters are the three-month figures the company reports; a fourth quarter marked derived is the fiscal year less the three reported quarters, since companies report it only inside the 10-K. Fiscal years are the annual figures. Buybacks are the cash the company paid to repurchase its common stock in the year, not the amount authorized. Balance sheet lines are as of 2026-09-30; shares outstanding as of 2010-02-17 from the cover page.
What this page is
CME Group in the regulatory record
Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.
Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.
This page follows CME Group (CME), SEC CIK 1156375, listed on Nasdaq, classified by the SEC as security & commodity brokers, dealers, exchanges & services. The cross-market tables live on the short interest and insider transactions hubs.
Source and updates
- Short interest
- FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
- Daily short volume
- FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
- Fails to deliver
- SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-13.JSON and CSV
- Planned sales
- SEC EDGAR Form 144Source: SEC.New notices appear shortly after the SEC posts them; a notice is filed on or before the sale. Latest 2026-11-02.JSON and CSV
- Large holders
- SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-04-29.JSON and CSV
- 13F holders
- SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
- Financials
- SEC EDGAR 10-K and 10-Q filingsSource: SEC.Weekly; values are as filed in the 10-Q and 10-K. Latest 2026-09-30.JSON and CSV
- Earnings dates
- SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-10-21.JSON and CSV
- Insider trades
- SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-11-02.JSON and CSV
- Company record
- EDGAR filing index for CIK 1156375Ticker, name and exchange from the SEC's company list, refreshed weekly.
- Rate limits
- 10 requests a minute without a key, 30 with a free key from a free account.
How to read it
- Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
- Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
- Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.
Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.
Other companies the SEC classifies as security & commodity brokers, dealers, exchanges & services
Other company pages
Datasets
Frequently Asked Questions
How much of CME is sold short?
4,987,983 shares were held short at the 2026-10-15 settlement, 2.6 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.
What is CME's daily short volume?
On 2026-11-02, 283,869 of the 751,163 CME shares reported to FINRA were sold short, 37.8% of the day's reported volume. Short volume is a flow for one day, not a position.
Does CME have fails to deliver?
The SEC's latest file shows 1,121 CME shares failed to deliver at settlement 2026-10-13. Fails are reported per settlement date and published twice a month with a lag.
Are CME insiders buying or selling?
Over the last 90 days CME insiders reported 1 open-market buy ($79K) against 6 sells ($8.9M), so the dollar flow leans toward selling. Latest filing: Winkler Julie (Sr MD Chief Commercial Officer) on 2026-11-02.
Have CME insiders filed to sell?
18 Form 144 notices on file for CME worth $21.0M at the prices reported; 6 in the last 90 days worth $5.5M. Latest: JULIE WINKLER filed on 2026-11-02 to sell 10,079 shares ($3.1M) from 2026-11-02.
Who owns 5% or more of CME?
1 holder reports 5% or more of CME in its latest filing, on Schedule 13G (passive). The holder is Vanguard Capital Management at 7.5% of the class (27,044,709 shares), filed 2026-04-29 for an event on 2026-03-31.
What did CME report last quarter?
In Q3 FY 2026 (quarter ended 2026-09-30) CME Group reported revenue of $1.74B, up 13.0% from the same quarter a year earlier, and net income of $1.04B (2.89 diluted EPS). In FY 2025 it generated $4.28B of operating cash flow and spent $3.93B on dividends.
Which tracked 13F managers own CME?
11 of the 30 tracked 13F managers held CME shares at their latest filing, $2.36B in all. The largest: Two Sigma Investments (2.4M shares, $534.4M), Cliff Asness's AQR Capital Management (2.0M shares, $447.7M), Ken Griffin's Citadel Advisors (1.5M shares, $332.4M), D. E. Shaw & Co. (1.3M shares, $292.2M), Izzy Englander's Millennium Management (1.2M shares, $264.1M), Steve Cohen's Point72 Asset Management (744K shares, $164.2M). The table above lists all 11.
Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.